Detalhe da pesquisa
1.
Galectin-3 interacts with PD-1 and counteracts the PD-1 pathway-driven regulation of T cell and osteoclast activity in Rheumatoid Arthritis.
Scand J Immunol
; 97(2): e13245, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36537046
2.
Checkpoint Molecules in Rheumatology-or the Benefits of Being Exhausted.
Curr Rheumatol Rep
; 23(4): 22, 2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33651184
3.
Divergent effects on macrophage biomarkers soluble CD163 and CD206 in axial spondyloarthritis.
Scand J Clin Lab Invest
; 78(6): 483-489, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30176763
4.
Soluble CD206 plasma levels in rheumatoid arthritis reflect decrease in disease activity.
Scand J Clin Lab Invest
; 77(5): 385-389, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28598681
5.
Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs.
Clin Exp Rheumatol
; 33(4): 498-502, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25962601
6.
Galectin-3 Decreases 4-1BBL Bioactivity by Crosslinking Soluble and Membrane Expressed 4-1BB.
Front Immunol
; 13: 915890, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35812455
7.
Diminished Non-Classical Monocytes in the Blood Associate with Disease Severity in Alcoholic Hepatitis.
Clin Exp Gastroenterol
; 14: 259-267, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34135614
8.
The interleukin-20 receptor axis in early rheumatoid arthritis: novel links between disease-associated autoantibodies and radiographic progression.
Arthritis Res Ther
; 18: 61, 2016 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26968800
9.
CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic 'window of opportunity'.
Arthritis Res Ther
; 16(5): 434, 2014 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-25249397